Article info
A troublesome cough: from diagnosis to treatment
S34 The effects of a novel formulation of inhaled cromolyn sodium (pa101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, controlled, phase 2 trial
Citation
S34 The effects of a novel formulation of inhaled cromolyn sodium (pa101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, controlled, phase 2 trial
Publication history
- First published November 15, 2017.
Online issue publication
September 01, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions